Andreas Sturm
Med. Klinik m. S. Hepatologie
Gastroenterologie
Endokrinologie und Stoffwechsel; Charité-Universitätsmedizin
Berlin
Name/email consistency: high
- Concomitant Use of Immunomodulators with Anti-TNF in Crohn's Disease: Yes or No?. Meier, J., Sturm, A. Curr. Drug. Targets (2009)
- Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Sturm, A., Rilling, K., Baumgart, D.C., Gargas, K., Abou-Ghazalé, T., Raupach, B., Eckert, J., Schumann, R.R., Enders, C., Sonnenborn, U., Wiedenmann, B., Dignass, A.U. Infect. Immun. (2005)
- Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. Sturm, A., Lensch, M., André, S., Kaltner, H., Wiedenmann, B., Rosewicz, S., Dignass, A.U., Gabius, H.J. J. Immunol. (2004)